We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
Cap. Flow
-$2.97B
Cap. Flow %
-3.9%
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$77.3M
2
BX icon
Blackstone
BX
+$53.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$40.8M
4
PLTR icon
Palantir
PLTR
+$34.3M
5
SNOW icon
Snowflake
SNOW
+$24.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$163M
3
LIN icon
Linde
LIN
+$133M
4
AMZN icon
Amazon
AMZN
+$94.7M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.6M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Financials 14.16%
3 Healthcare 12.95%
4 Consumer Discretionary 12.06%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EBF icon
2126
Ennis
EBF
$564M
$1.32M ﹤0.01%
61,505
-5,336
-8% -$113K
EVOP
2127
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$1.32M ﹤0.01%
47,539
-1,550
-3% -$44.2K
UVE icon
2128
Universal Insurance Holdings
UVE
$1.23B
$1.32M ﹤0.01%
94,960
-3,973
-4% -$55.8K
MTW icon
2129
Manitowoc
MTW
$675M
$1.31M ﹤0.01%
53,537
-6,123
-10% -$146K
MOD icon
2130
Modine Manufacturing
MOD
$10.4B
$1.31M ﹤0.01%
79,001
-9,945
-11% -$163K
CCCC icon
2131
C4 Therapeutics
CCCC
$412M
$1.31M ﹤0.01%
34,565
+24,284
+236% +$870K
NEX
2132
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$1.3M ﹤0.01%
273,458
-28,219
-9% -$124K
KPTI icon
2133
Karyopharm Therapeutics
KPTI
$48M
$1.3M ﹤0.01%
8,379
+317
+4% +$46K
NTST
2134
NETSTREIT Corp
NTST
$2.1B
$1.29M ﹤0.01%
56,052
+30,278
+117% +$661K
LPG icon
2135
Dorian LPG
LPG
$1.96B
$1.29M ﹤0.01%
91,407
-13,917
-13% -$195K
CAMP
2136
DELISTED
CalAmp Corp.
CAMP
$1.29M ﹤0.01%
4,401
-284
-6% -$84.7K
DENN
2137
DELISTED
Denny's
DENN
$1.29M ﹤0.01%
77,976
-8,716
-10% -$153K
NHC icon
2138
National Healthcare
NHC
$3.37B
$1.29M ﹤0.01%
18,400
-2,400
-12% -$174K
FFWM
2139
DELISTED
First Foundation Inc
FFWM
$1.28M ﹤0.01%
56,759
-2,146
-4% -$51.5K
IBRX icon
2140
ImmunityBio
IBRX
$8.1B
$1.27M ﹤0.01%
89,140
+51,249
+135% +$847K
FRG
2141
DELISTED
Franchise Group, Inc.
FRG
$1.27M ﹤0.01%
35,916
+4,767
+15% +$175K
ECOM
2142
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$1.26M ﹤0.01%
51,562
+1,108
+2% +$26.6K
GSBC icon
2143
Great Southern Bancorp
GSBC
$878M
$1.25M ﹤0.01%
23,271
-2,461
-10% -$138K
VCRA
2144
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1.25M ﹤0.01%
31,379
-1,598
-5% -$58.3K
ALGM icon
2145
Allegro MicroSystems
ALGM
$8.16B
$1.25M ﹤0.01%
44,931
+7,412
+20% +$193K
TRIL
2146
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.25M ﹤0.01%
+128,383
New +$1.21M
SRI icon
2147
Stoneridge
SRI
$213M
$1.24M ﹤0.01%
42,117
-6,092
-13% -$193K
ATRS
2148
DELISTED
Antares Pharma, Inc.
ATRS
$1.24M ﹤0.01%
284,654
+17,518
+7% +$71.4K
ACCO icon
2149
Acco Brands
ACCO
$407M
$1.24M ﹤0.01%
143,512
-15,406
-10% -$137K
LBAI
2150
DELISTED
Lakeland Bancorp Inc
LBAI
$1.24M ﹤0.01%
70,661
-8,728
-11% -$158K

Similar funds

RhumbLine Advisers's Q2 2021 Portfolio in Review

As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.

  • RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
  • RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
  • RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
  • RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
  • RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
  • RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.

Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.